- Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
- Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference
- Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
- Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024
- Collegium Provides 2024 Financial Guidance
- Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent
- Collegium Announces $25 Million Accelerated Share Repurchase Program
- Collegium to Participate in Upcoming Investor Conferences
- Collegium Reports Third Quarter 2023 Financial Results
- Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023
More ▼
Key statistics
As of last trade Collegium Pharmaceutical Inc (COLL:NSQ) traded at 35.65, -12.94% below its 52-week high of 40.95, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 35.00 |
---|---|
High | 36.01 |
Low | 34.92 |
Bid | 35.64 |
Offer | 35.71 |
Previous close | 34.74 |
Average volume | 338.37k |
---|---|
Shares outstanding | 32.71m |
Free float | 32.25m |
P/E (TTM) | 39.38 |
Market cap | 1.14bn USD |
EPS (TTM) | 0.8823 USD |
Data delayed at least 15 minutes, as of Apr 23 2024 16:48 BST.
More ▼